Introduction: Achieving a goal of serum urate levels in patients with gout is an important way to prevent gout and its complications while it remains difficult with a low targeting rate worldwidely.

A recent study by researchers from the University of California San Diego and collaborators has uncovered a new molecular ...

The consensus-based and validated OMERACT ultrasound structural gout lesions show sensitivity to change. The double contour sign and tophus show statistically significant decreases during ...

The secondary objective was to test the concurrent validity of US abnormalities using as gold standard the microscopic demonstration of monosodium urate (MSU) crystals. Methods Ninety-one men with ...

Gout is a type of inflammatory arthritis that develops when high uric acid levels in the body form urate crystals in joints and other structures. This condition most commonly affects the big toe ...

Natural stone formed in the human kidney, after the operation of the stone. gout crystals stock videos & royalty-free footage Macro shooting A stone from a human kidney close-up, measuring the size of ...

Giloy is renowned for its immune-boosting properties. A strong immune system can help the body fight off infections and ...

1 Department of Orthopaedics, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 2 College of Nursing, Hangzhou Normal University, Hangzhou, China Objective: Gout is a common ...

Colchicine may Reduce CV Event Risk with Urate-Lowering Therapy for Gout, suggests a study published in The Lancet Rheumatology. Researchers have found in a new study that colchicine may Reduce CV ...

Without treatment, gout can reoccur several times a year and cause erosion and destruction in the affected joints. Urate crystals can also accumulate in the urinary tracts of people with gout, which ...

Colchicine for gout flare prophylaxis reduces the risk for cardiovascular events among patients initiating urate-lowering therapy, according to data published in The Lancet Rheumatology.